Teva Pharmaceutical Industries Gets Approval to Launch Generic Equivalent to Novartis' Diovan in the U.S

Teva Pharmaceutical Industries Limited said that the Food and Drug Administration (FDA) has approved the company's generic equivalent to Diovan (Valsartan) Tablets.
Diovan (Valsartan), marketed by Novartis Pharmaceuticals, is for the treatment of high blood pressure and heart failure.